Jane Street Group, LLC Meridian Bioscience Inc Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $681,219 - $730,205	21,869 Added 144.24%	37,031 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $134,415 - $145,942	4,350 Added 40.23%	15,162 $478,000
Q2 2022 Aug 16, 2022	SELL	$23.75 - $31.69 $379,762 - $506,723	-15,990 Reduced 59.66%	10,812 $329,000
Q1 2022 May 17, 2022	SELL	$19.97 - $26.94 $6,410 - $8,647	-321 Reduced 1.18%	26,802 $696,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $48,086 - $75,614	2,670 Added 10.92%	27,123 $602,000
Q1 2021 May 18, 2021	BUY	$19.76 - $29.89 $60,445 - $91,433	3,059 Added 14.3%	24,453 $642,000
Q3 2020 Nov 17, 2020	SELL	$13.54 - $26.41 $154,288 - $300,941	-11,395 Reduced 34.75%	21,394 $363,000
Q2 2020 Aug 17, 2020	BUY	$7.84 - $23.29 $120,398 - $357,664	15,357 Added 88.1%	32,789 $764,000
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $97,096 - $200,468	17,432 New	17,432 $146,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.2 $138,151 - $162,178	-10,011 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$13.55 - $15.8 $135,649 - $158,173	10,011	10,011 $140,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.